Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Yuka Pharmaceutical Co Ltd
Original Assignee
Mitsubishi Yuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Yuka Pharmaceutical Co LtdfiledCriticalMitsubishi Yuka Pharmaceutical Co Ltd
Priority to JP13872779ApriorityCriticalpatent/JPS5663967A/ja
Priority to US06/199,565prioritypatent/US4607034A/en
Priority to CA000363320Aprioritypatent/CA1141378A/en
Priority to EP80106648Aprioritypatent/EP0028031B1/en
Priority to DE8080106648Tprioritypatent/DE3064773D1/de
Publication of JPS5663967ApublicationCriticalpatent/JPS5663967A/ja
Publication of JPS6313991B2publicationCriticalpatent/JPS6313991B2/ja
Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
Lower alkanoic acid derivative, salt and preparation thereof and preventing agent and remedy for diabetic complication containing the same as active constituent